Illumina, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ILMN research report →
About the company
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains.
- CEO
- Jacob Thaysen
- IPO
- 2000
- Employees
- 8,970
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $28.55B
- P/E
- 34.06
- P/S
- 6.50
- P/B
- 10.79
- EV/EBITDA
- 21.31
- Div Yield
- 0.00%
- Gross Margin
- 67.66%
- Op Margin
- 21.45%
- Net Margin
- 19.43%
- ROE
- 33.99%
- ROIC
- 13.59%
- Revenue
- $4.34B · -0.78%
- Net Income
- $850.00M · 169.50%
- EPS
- $5.48 · 171.26%
- Op Income
- $864.00M
- FCF YoY
- 31.31%
- 52W High
- $189.46
- 52W Low
- $88.00
- 50D MA
- $152.95
- 200D MA
- $130.23
- Beta
- 1.47
- Avg Volume
- 1.81M
Get TickerSpark's AI analysis on ILMN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Meister Keith A. | other | 142 |
| Jun 30, 26 | Ullem Scott B. | other | 167 |
| Jun 25, 26 | Davies Scott M | sell | 615 |
| Jun 16, 26 | Skovronsky Daniel | other | 1,674 |
| Jun 16, 26 | Skovronsky Daniel | other | 0 |
| Jun 5, 26 | Leckman Patricia | sell | 290 |
| Jun 5, 26 | Leckman Patricia | sell | 374 |
| Jun 5, 26 | Leckman Patricia | sell | 78 |
| Jun 5, 26 | Leckman Patricia | sell | 39 |
| Jun 5, 26 | Leckman Patricia | sell | 2 |
Our ILMN coverage
Recent articles, reports, and earnings notes.
No research on ILMN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ILMN report →Similar companies
Peers in the same neighborhood.